Another quarter of strong growth, but slower growth clouds building up on the horizon here and there. Both Smith+Nephew and ConvaTec have newly appointed CEOs.
For Q319, according to SmartTRAK’s Financial Dashboard, WW Advanced Wound Care (AWC) revenue for Advanced Dressings, External Devices and Biologics was up +5.9% YoY.
Acelity remained the WW AWC market leader, up +6.3% YoY, driven by Prevena and the Crawford acquisition. WW Advanced Dressings saw several strong shifts in the ranking of companies, with ConvaTec moving up to the 2nd position, surpassing Smith + Nephew (S+N), after ConvaTec recovering, but S+N facing continued declining growth. Mölnlycke led the market and Coloplast was the strongest growing of the top four. The total market was up +3.2% YoY. US Skin/Dermal Substitute (CTP) revenue increased, with xenografts, especially Organogenesis’ PuraPly, driving gains. WW NPWT was up +8.2% YoY, with traditional devices up +3.4% and single-use...Among the many topics covered in the complete, comprehensive Q319 Advanced Wound Care Market Recap* are: